Homandberg G A, Erickson J W
Biochemistry. 1986 Nov 4;25(22):6917-25. doi: 10.1021/bi00370a027.
Human plasma fibronectin aggregates in solution and is thought to form fibrils on cell surfaces, perhaps by self-associating and by interacting with other components such as proteoglycans. We have localized the self-association domains by testing the ability of various fragments of fibronectin to interact with each other. Complexation between fluorescamine-labeled fragments and unlabeled fragments or whole molecules was assessed by gel filtration high-performance liquid chromatography. The fragments studied included nonoverlapping fragments that are situated on the fibronectin polypeptide chain in the following order, beginning from the amino terminus: the 29-, 50-, 120-, 35-, and 25-kDa fragments, as well as multiple-domain fragments of 72 kDa containing the 29- and 50-kDa segments, a fragment of 150 kDa containing the 120- and 35-kDa segment, a fragment of 190 kDa containing the 120- and 35-kDa segments, a fragment of 190 kDa containing the 50-, 150-, and 25-kDa segments, and a 45-kDa fragment containing the 35-kDa segment. The amino-terminal 29-kDa fragment bound to the carboxyl-terminal heparin-binding (Hep II) 35-kDa fragment as well as the 150- and 190-kDa fragments that contain the 35-kDa segment. On the other hand, carboxyl-terminal 35- and 45-kDa Hep II containing fragments bound to each other as well as to amino-terminal 29- and 72-kDa fragments and to the 190-kDa fragment. Further, the 25-kDa carboxyl-terminal fibrin-binding fragment bound the 190-kDa fragment, the only fragment containing the 25-kDa segment.(ABSTRACT TRUNCATED AT 250 WORDS)
人血浆纤连蛋白在溶液中会聚集,并且被认为可能通过自身缔合以及与蛋白聚糖等其他成分相互作用在细胞表面形成纤维。我们通过测试纤连蛋白不同片段之间相互作用的能力来定位自身缔合结构域。通过凝胶过滤高效液相色谱法评估了荧光胺标记片段与未标记片段或完整分子之间的复合情况。所研究的片段包括不重叠的片段,这些片段按从氨基末端开始的以下顺序位于纤连蛋白多肽链上:29 kDa、50 kDa、120 kDa、35 kDa和25 kDa片段,以及包含29 kDa和50 kDa片段的72 kDa多结构域片段、包含120 kDa和35 kDa片段的150 kDa片段、包含120 kDa和35 kDa片段的190 kDa片段、包含50 kDa、150 kDa和25 kDa片段的190 kDa片段,以及包含35 kDa片段的45 kDa片段。氨基末端的29 kDa片段与羧基末端的肝素结合(Hep II)35 kDa片段以及包含35 kDa片段的150 kDa和190 kDa片段结合。另一方面,羧基末端含35 kDa和45 kDa Hep II的片段彼此结合,也与氨基末端的29 kDa和72 kDa片段以及190 kDa片段结合。此外,25 kDa羧基末端的纤维蛋白结合片段与190 kDa片段结合,190 kDa片段是唯一包含25 kDa片段的片段。(摘要截短于250字)